Elizabeth Egan joins Patient Discovery as VP, Marketing
Patient Discovery Solutions, a leader in patient-provider engagement technologies that harness the voice of the patient and the power of real-world data to achieve better health outcomes, announced the addition of Elizabeth Egan to the position of Vice President, Marketing. In this role, Ms. Egan will focus on developing marketing strategies that maximize awareness and market share of Patient Discovery’s innovative solutions across US health systems, life sciences, and health plan organizations.
“We are excited to welcome Beth to Patient Discovery, and we look forward to having her leadership as we work to accelerate market awareness, interest, and engagement with our brand,” said Adam Sodowick, Chief Innovation Officer and Co-Founder of Patient Discovery. “Patient Discovery is filling a truly unmet need by helping reduce barriers to the delivery of equitable care and better health outcomes for every patient. Having Beth on board will help ensure that our message reaches the broadest audience possible as we work together to move healthcare forward.”
“We are excited to welcome Beth to Patient Discovery, and we look forward to having her leadership as we work to accelerate market awareness, interest, and engagement with our brand,” said Adam Sodowick, Chief Innovation Officer and Co-Founder of Patient Discovery. “Patient Discovery is filling a truly unmet need by helping reduce barriers to the delivery of equitable care and better health outcomes for every patient. Having Beth on board will help ensure that our message reaches the broadest audience possible as we work together to move healthcare forward.”
Ms. Egan brings extensive strategic marketing experience, gained from nearly 20 years engaging with health systems, life sciences and health plan organizations across the United States. Most recently she served as the product marketing lead for the healthcare technology start-up, Cohere Health. Prior to Cohere, she held marketing leadership roles for YourEncore, acquired by Advarra; IQVIA (NYSE: IQV); and StayWell, acquired by WebMD.